Cipla announced that it has received final approval from the United States Food and Drug Administration (USFDA) for the new drug application (NDA) submitted for 'Nilotinib Capsules 50, 150 and 200 mg' ...
In a press release issued after market hours on February 20, Cipla announced that it has received approval for Nilotinib ...
Down syndrome, or trisomy 21, is caused by the presence of a third copy of the 21st chromosome. Affected individuals have ...
Cipla has received final US FDA approval for its Nilotinib Capsules (50 mg, 150 mg, 200 mg) for the treatment of Philadelphia ...
A recent Trump executive order defines sex based on gamete size. But the order oversimplifies genetics, hormones and reproductive biology.
Nilotinib is an FDA approved drug used for the treatment of Philadelphia Chromosome Positive CML, which is a cancer of blood ...
In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...
"We were delighted to discover not only important details about the mechanisms of HBV gene regulation, but also a promising ...
Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat chronic infections for the first time.
18h
Live Science on MSNNorrie disease: The rare genetic disorder that makes people go blind and deafNorrie disease is an extremely rare, inherited genetic disorder that causes vision loss and was first described in Denmark in ...
Learn about the promising advance in prenatal treatment of spinal muscular atrophy, introducing a potential approach to suppress symptoms of the disorder in infants.
In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results